NCT07287098 2026-04-17
preEMBER
Eli Lilly and Company
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT07310420 2026-03-11
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
TerSera Therapeutics LLC
Phase 1 Not yet recruiting
NCT05131893 2021-11-23
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary
Not yet recruiting